Bringing the fundamentals into focus…
Back to Viridian Therapeutics, Inc.
How Viridian Therapeutics, Inc. stacks up
VRDN · against 340 other Healthcare companies of similar size
Profitability
7/ 100
Near the bottom of its peers.
Ranked #319 of 341 · scores higher than 6% of peers
Bars: peers in each 10-point band of the profitability score27 peers with a profitability score of 0–9, including VRDN · Click a bar to see the companies
Why profitability scores 7?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 93% of peers. Operating margin: -569.7% vs peer median 7.1%
- a lower return on assets: weaker than 89% of peers. Return on assets: -35.3% vs peer median 1.7%
- a lower return on invested capital: weaker than 89% of peers. Return on invested capital: -61.8% vs peer median 4.7%
Metric by metric
Position: dot = VRDN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VRDN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 324 reported | -61.8% | 6.9% | 9% | 33% | |
| Operating marginHigher is better · 316 reported | -569.7% | 9.5% | 6% | 33% | |
| Return on assetsHigher is better · 325 reported | -35.3% | 2.5% | 10% | 33% | |
| Return on equityHigher is better · 314 reported | -65.7% | 6.3% | 10% | Context only | |
| Gross marginHigher is better · 349 reported | 0.0% | 48.4% | 3% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around VRDN| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 316 | 2.4B USD | 8 | 6 | |
| 316 | 1.9B USD | 8 | 18 | |
| 316 | 5.4B USD | 8 | 24 | |
| 319 | 2.4B USD | 7 | 20 | |
| 319 | 2.8B USD | 7 | 51 | |
| 321 | 1.5B USD | 6 | 30 | |
| 321 | 2.2B USD | 6 | 20 | |
| 323 | 5.7B USD | 5 | 52 | |
| 323 | 4.8B USD | 5 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score